Bangladesh vs Europe and Northern America: Proportion of the target population who received a 3rd dose of
Bangladesh
97.0%
in 2024
Europe and Northern America
83.0%
in 2024
Bangladesh rank
11th
Europe and Northern America rank
9th
Proportion of the target population who received a 3rd dose of over time
- Bangladesh
- Europe and Northern America
How they compare
Bangladesh currently reports 97.0% against 83.0% in Europe and Northern America, a difference of 14.0%.
That makes Bangladesh's figure about 1.2 times Europe and Northern America's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Europe and Northern America ahead.
Bangladesh ranks 11th and Europe and Northern America ranks 9th of 157 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Europe and Northern America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.2% | 74.0% | 14.2% | Bangladesh |
| 2020s | 97.4% | 82.4% | 15.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Bangladesh or Europe and Northern America?
- Bangladesh, at 97.0% against 83.0% in Europe and Northern America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Bangladesh and Europe and Northern America?
- 14.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Europe and Northern America?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Europe and Northern America rank globally for proportion of the target population who received a 3rd dose of?
- Bangladesh ranks 11th and Europe and Northern America ranks 9th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.